Utility Values for Patients with Advanced Gastrointestinal Stromal Tumors (GIST) Treated with Regorafenib Versus Placebo in the Phase III Grid Trial
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.552
https://www.valueinhealthjournal.com/article/S1098-3015(13)02457-1/fulltext
Title :
Utility Values for Patients with Advanced Gastrointestinal Stromal Tumors (GIST) Treated with Regorafenib Versus Placebo in the Phase III Grid Trial
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02457-1&doi=10.1016/j.jval.2013.08.552
First page :
A419
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
532